Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

We have observed 69 EP applications Edward Christopher Oates has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 25, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14163968

Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters

IPC classification:
A61K 31/443, C07D 405/12, A61P 11/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12794811

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

IPC classification:
A61K 31/553, A61K 31/405, C07D 498/04, C07D 405/14, C07D 405/12, A61P 35/00, A61P 27/00, A61P 25/00, A61P 11/00, A61P 3/00, A61P 1/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP14168373

Modulators of CFTR

IPC classification:
A61K 31/444, C07D 405/14, C07D 401/04, A61P 37/00, A61P 11/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12787303

USE OF (N- [2, 4 -BIS (1, 1 -DIMETHYLETHYL) - 5 - HYDROXYPHENYL]- 1, 4 - DIHYDRO - 4 - OXOQUINOLINE - 3 - CARBOXAMIDE) FOR TREATING CFTR MEDIATED DISEASES

IPC classification:
A61K 31/47
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP14184159

Compositions for treatment of cystic fibrosis and other chronic diseases

IPC classification:
A61K 45/06, A61K 31/501, A61K 31/4965, A61K 31/443, A61K 31/404, A61P 43/00, A61P 19/10, A61P 11/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13706858

METHODS FOR TREATING AN IMPAIRMENT IN GAIT AND/OR BALANCE IN PATIENTS WITH MULTIPLE SCLEROSIS USING AN AMINOPYRIDINE

IPC classification:
A61K 31/505, A61P 25/14
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13749829

FORMULATIONS OF BENDAMUSTINE

IPC classification:
A61K 31/4184, A61P 35/00
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Olga Capasso, De Simone & Partners Spa
Status:
EXAMINATION IN PROGRESS
EP14182117

Process for making modulators of cystic fibrosis transmembrane conductance regulator

IPC classification:
C07D 215/233
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP14164892

Azaindole derivatives as CFTR modulators

IPC classification:
A61K 31/437, C07D 471/04, A61P 25/00, A61P 3/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP14172991

Solid amorphous form of (R)-1(2,2-difluorobenzo(D)(1,3)dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)-cyclopropanecarboxamide

IPC classification:
A61K 31/404, C07D 405/12, A61P 11/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13764989

FORMULATIONS OF BENDAMUSTINE

IPC classification:
A61K 31/4184
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Olga Capasso, De Simone & Partners Spa
Status:
GRANT OF PATENT INTENDED
EP13765020

METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION

IPC classification:
A61K 31/4184
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Olga Capasso, De Simone & Partners Spa
Status:
The patent has been granted
EP13731230

METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN

IPC classification:
A61K 31/517, A61K 31/513, A61K 31/4745, A61K 9/00, A61P 35/00
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
PATENT GRANTED
EP13860427

COMBINATION THERAPY FOR TREATING HER2-POSITIVE CANCERS

IPC classification:
A61K 39/395, A61K 9/127, A61P 35/00
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Deborah Mary Hart, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13826678

3,5-DIAMINO-6-CHLORO-N-(N-(4-PHENYLBUTYL)CARBAMIMIDOYL) PYRAZINE-2- CARBOXAMIDE COMPOUNDS

IPC classification:
A61K 31/4965, C07D 241/20, A61P 11/12
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
The patent has been granted
EP13814392

CHLORO-PYRAZINE CARBOXAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES FAVOURED BY INSUFFICIENT MUCOSAL HYDRATION

IPC classification:
A61K 31/4965, C07D 241/26, A61P 11/12
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP13815644

ARYLALKYL-AND ARYLOXYALKYL-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS

IPC classification:
A61K 31/4965, C07D 241/20, A61P 11/12
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
The patent has been granted
EP15184092

3,5-DIAMINO-6-CHLORO-N-(N-(4-(4-(2-(HEXYL(2,3,4,5,6-PENTA-HYDROXYHEXYL)AMINO)ETHOXY)PHENYL)BUTYL) CARBAMIMIDOYL)PYRAZINE-2-CARBOXAMIDE

IPC classification:
A61P 11/00, A61K 31/4965, C07D 239/48
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
EXAMINATION REQUESTED
EP16152270

SOLID FORM OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE

IPC classification:
A61P 11/00, A61K 31/47, C07D 215/56
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP14781337

LIQUID PROTEIN FORMULATIONS CONTAINING WATER SOLUBLE ORGANIC DYES

IPC classification:
A61K 47/20, A61K 38/00, A61K 9/19, A61K 39/00, A61K 9/00, C07K 1/14, A61K 39/395, A61K 47/18, A61K 9/08
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14781338

LIQUID PROTEIN FORMULATIONS CONTAINING ORGANOPHOSPHATES

IPC classification:
A61K 47/18, A61K 39/00, A61K 9/19, C07K 1/14, A61K 38/00, A61K 47/20, A61K 9/00
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP16194421

CHLORO-PYRAZINE CARBOXAMIDE DERIVATIVES WITH EPITHELIAL SODIUM CHANNEL BLOCKING ACTIVITY

IPC classification:
A61P 11/12, A61K 31/4965, C07D 241/26
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15771464

PHENYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS

IPC classification:
C07D 409/12, C07D 405/12, C07D 471/04, C07D 215/227, A61K 31/4709, A61K 31/4704, A61P 35/00, C07D 401/12
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Status:
Request for examination was made
EP15771465

PYRIDINYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS

IPC classification:
A61K 31/4709, A61K 31/4704, A61P 35/00, C07D 417/14, C07D 401/12, C07D 413/14, C07D 405/14, C07D 401/14
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Status:
The patent has been granted
EP15787846

CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL]PYRIMIDINE-2,4-DIAMINE

IPC classification:
A61P 35/00, A61K 31/506, C07D 239/48
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Jones Day
Status:
Request for examination was made
EP15790211

METHOTREXATE FORMULATION

IPC classification:
A61K 31/519, A61K 9/00, A61K 47/12, A61K 47/10
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Gill Jennings & Every LLP
Status:
Request for examination was made
EP17160386

DEUTERATED DERIVATIVES OF IVACAFTOR

IPC classification:
A61P 11/12, A61K 31/47, C07B 59/00, C07D 215/56
Applicant:
Concert Pharmaceuticals Inc
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
Request for examination was made
EP15832772

PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS

IPC classification:
A61K 31/519, C07D 487/04
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Status:
Request for examination was made
EP16705662

THIENOPYRIMIDINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS

IPC classification:
A61P 35/00, A61P 31/00, A61P 37/00, A61P 25/00, A61K 31/519, C07D 495/04
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Status:
Request for examination was made
EP16705410

ISOTHIAZOLOPYRIMIDINONES, PYRAZOLOPYRIMIDINONES, AND PYRROLOPYRIMIDINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS

IPC classification:
A61P 35/00, A61P 31/00, A61P 29/00, A61K 31/519, C07D 513/04, C07D 487/04
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Status:
Request for examination was made
EP16706457

3-ALKYL-4-AMIDO-BICYCLIC [4,5,0]HYDROXAMIC ACIDS AS HDAC INHIBITORS

IPC classification:
A61P 35/00, A61K 31/553, A61K 31/551, C07D 267/12, C07D 243/14, C07D 413/06, C07D 403/06
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Status:
Request for examination was made
EP16711758

ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS

IPC classification:
C07D 401/04, C07D 233/68, C07D 333/70, C07D 233/38, C07D 233/36, C07D 231/18, C07D 231/14, C07D 317/68, C07C 275/30, C07D 215/12, C07D 213/81, A61P 35/00, C07C 259/06, C07D 213/75, C07D 401/14
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Status:
Request for examination was made
EP16704357

3-ARYL-4-AMIDO-BICYCLIC [4,5,0]HYDROXAMIC ACIDS AS HDAC INHIBITORS

IPC classification:
A61P 35/00, A61K 31/553, A61K 31/551, C07D 267/12, C07D 243/14, C07D 413/06, C07D 403/06
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Status:
Request for examination was made
EP16849524

ADMINISTRATION OF DEUTERATED CFTR POTENTIATORS

IPC classification:
C07D 215/56, A61K 31/47
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16778627

SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE

IPC classification:
A61K 31/4409, A61K 9/28
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16788877

STABILIZING CAMPTOTHECIN PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 31/4745, A61K 9/127
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18153008

AQUEOUS SUSPENSIONS OF TMC278

IPC classification:
A61K 31/00, A61K 9/14, A61K 9/00
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Liesbeth Vervoort, J&J Patent Law Department
Status:
Request for examination was made
EP16791511

DIBENZO AZEPINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF OTIC DISEASES AND DISORDERS

IPC classification:
A61K 31/55, C07D 223/18
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP16805697

PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS

IPC classification:
A61P 35/00, A61K 31/522, C07D 473/00
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Status:
Request for examination was made
EP18173910

INTERMEDIATE COMPOUND FOR PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS

IPC classification:
C07D 405/12, C07D 317/60, C07D 209/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16871328

TOPICAL FORMULATIONS

IPC classification:
C07D 401/00, A01N 37/18, C07K 16/28
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16876677

COMBINATIONS FOR THE TREATMENT OF CANCER

IPC classification:
C12Q 1/68, A61P 35/00, A61K 31/416, A61K 31/00
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18182201

HETEROARYL COMPOUNDS FOR KINASE INHIBITION

IPC classification:
C07D 401/04, C07D 471/04, C07D 405/12, C07D 403/14, C07D 405/14, C07D 401/14, C07D 403/04
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18167730

MACROCYCLIC POLYMORPHS, COMPOSITIONS COMPRISING SUCH POLYMORPHS, AND METHODS OF USE AND MANUFACTURE THEREOF

IPC classification:
A61P 31/04, A61K 31/7048, C07H 17/08
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17708031

THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

IPC classification:
A61P 37/00, A61P 31/12, A61P 31/04, A61P 29/00, A61P 35/00, A61K 31/506, A61K 31/5386, A61K 31/437, A61K 31/438, A61K 31/551, A61K 31/4985, A61K 31/496, A61K 31/4365, C07D 495/04
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17706132

THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

IPC classification:
A61P 37/00, A61P 35/00, A61K 31/4985, C07D 495/04
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17753910

ORITAVANCIN FORMULATIONS

IPC classification:
A61P 31/04, A61K 47/40, A61K 38/14
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17750825

DEUTERIUM-MODIFIED CFTR MODULATORS

IPC classification:
A61P 25/16, A61P 11/00, A61K 51/04, C07B 59/00, C07D 495/04, C07D 411/02, C07D 403/02
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18173500

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MEDIATED DISEASES

IPC classification:
A61K 9/20, A61K 9/16, A61K 9/14, C07D 209/04, C07D 215/00, A61K 31/47, A61K 31/404, A61K 45/06
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
The application has been published
EP18172451

METHODS FOR TREATING SENSORIMOTOR IMPAIRMENTS ASSOCIATED WITH CERTAIN TYPES OF STROKE USING AMINOPYRIDINES

IPC classification:
A61K 9/20, A61P 25/00, A61P 9/10, A61K 31/4409
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
The application has been published
EP17716763

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

IPC classification:
A61K 31/44, A61P 11/00, C07D 213/82, C07D 401/14
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18198969

PYRIDIN-2(1H)-ONE QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS

IPC classification:
C07D 409/12, C07D 405/12, C07D 471/04, C07D 215/227, A61K 31/4709, A61K 31/4704, A61P 35/00, C07D 401/12
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
The application has been published
EP18716455

PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS

IPC classification:
A61P 7/00, C07D 519/00, A61K 31/407, C07D 487/04
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP17723902

FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE

IPC classification:
A61P 35/00, A61K 31/565, A61K 47/32, A61K 47/10, A61K 9/10, A61K 9/00
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17824829

METHODS FOR MAKING ULTRASOUND CONTRAST AGENTS

IPC classification:
A61K 49/22
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17734449

NANOLIPOSOMAL IRINOTECAN FOR USE IN TREATING SMALL CELL LUNG CANCER

IPC classification:
A61K 9/127, A61P 35/00, A61K 31/4745
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17790287

METHODS OF USING FASN INHIBITORS

IPC classification:
C07D 471/04, C07D 403/04, C07D 401/04, A61P 1/16, A61K 31/496, A61K 31/495
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18192504

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES

IPC classification:
A61K 31/47, A61K 31/443, A61K 45/06, A61K 9/20
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
The application has been published
EP17735280

2-SPIRO-5- AND 6-HYDROXAMIC ACID INDANES AS HDAC INHIBITORS

IPC classification:
A61P 25/00, A61P 29/00, A61K 31/444, A61K 31/4439, A61K 31/4747, A61K 31/403, A61P 35/00, C07D 221/20, C07D 401/06, C07D 401/04, C07D 209/54
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Status:
Request for examination was made
EP17743115

SUBSTITUTED HYDANTOIN AND THIOHYDANTOIN DERIVATIVES AS ANDROGEN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4545, A61K 31/506, A61K 31/454, A61P 35/00, C07D 401/14, C07D 401/12
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17748965

THIOHYDANTOIN ANDROGEN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/5377, A61K 31/506, A61K 31/497, A61K 31/496, A61K 31/4545, A61K 31/4439
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18209919

PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS

IPC classification:
A61P 7/00, C07D 519/00, A61K 31/407, C07D 487/04
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Examination is in progress
EP17743188

METHODS, COMPOSITIONS AND KITS FOR INCREASING GENOME EDITING EFFICIENCY

IPC classification:
C12N 15/10, C07D 401/14
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17754226

METHODS OF TREATING PROSTATE CANCER

IPC classification:
A61P 35/00, A61K 31/454
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17837447

COMBINATIONS FOR THE TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 39/395, A61K 31/4725
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17778334

THIOHYDANTOIN ANDROGEN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/4439
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17844308

COMBINATIONS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 45/06, A61K 31/444, A61K 31/435
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17791221

METHODS OF DIAGNOSING AND TREATING ABIRATERONE ACETATE- GLUCOCORTICOID -RESISTANT OR -SENSITIVE METASTATIC CASTRATION RESISTANT PROSTATE CANCER

IPC classification:
C12Q 1/68
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17792230

MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR

IPC classification:
A61P 11/12, A61K 31/4439, C07D 498/14, C07D 471/14, C07D 401/14
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made

Please Sign in to use this feature